Barclays Initiates Coverage of PROCEPT BioRobotics with Overweight Rating
Fintel reports that on October 7, 2026, Barclays initiated coverage of PROCEPT BioRobotics (NASDAQGM:PRCT) (BMV:PRCT) with a Overweight recommendation.
Prior to this rating action, the stock closed at $17.51 on October 6, 2026. PROCEPT BioRobotics has experienced recent downward pressure, with a price change of -3.90% over one week, relative to a baseline close of $18.22 on September 29, 2026. Over a one-month period, the stock declined -23.07% from its baseline close of $22.76 on September 4, 2026.
Separately from the individual action by Barclays, the broader analyst consensus target for the stock was recorded on October 2, 2026. The current consensus target mean stands at $24.72, while the median target is $21.42. This mean target represents an implied change of +41.15% from recent levels.
In terms of aggregate recommendations, as of the September 1, 2026 period, the company had a total of 21 recommendations. These consisted of 3 strong buy, 7 buy, 10 hold, and 1 sell recommendations, reflecting 47.6% positive, 47.6% hold, and 4.8% negative recommendations. This represents a shift from the prior period of August 1, 2026, when the company had 4 strong buy, 8 buy, and 8 hold recommendations, representing 57.1% positive and 38.1% hold ratings.
PROCEPT BioRobotics last reported earnings on August 4, 2026. For that quarter, the company reported an actual EPS of -0.47, compared to an estimated EPS of -0.4661. Actual revenue for the period reached $94,498,000.00, compared to the estimated revenue of $94,751,227.00. The company's upcoming earnings announcement is scheduled for October 29, 2026, during the amc session.
Recent analyst actions
| Date | Analyst | Prior | Latest recommendation | Action |
|---|---|---|---|---|
| October 7, 2026 | Barclays | Overweight | initiated coverage |
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.